"Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.

Clicks: 208
ID: 86492
2020
Article Quality & Performance Metrics
Overall Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Many people living with HIV (PLWHIV) state that they would be willing to take significant risks to be "cured" of the virus. However, how they interpret the word "cure" in this context is not clear. We used a randomized survey to examine whether PLWHIV had a different willingness to take a hypothetical HIV medication if it causes flu-like symptoms, but provides: (a) cure, (b) remission that was labeled "cure", or (c) remission. PLWHIV (n = 454) were more willing to take a medication that provided a "cure" versus a "remission" if the side effects lasted less than 1 year. PLWHIV were more willing to take a medication that provided a remission that was labeled "cure" versus a "remission" (p = 0.01) if the side effects lasted 2 weeks. Clinicians and researchers should be aware of the impact of the word "cure" and ensure that PLWHIV fully understand the possible outcomes of their treatment options.
Reference Key
fridman2020cureaids Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Fridman, Ilona;Ubel, Peter A;Blumenthal-Barby, Jennifer;England, Cameron V;Currier, Judith S;Eyal, Nir;Freedberg, Kenneth A;Halpern, Scott D;Kelley, Colleen F;Kuritzkes, Daniel R;Le, Catherine N;Lennox, Jeffrey L;Pollak, Kathryn I;Zikmund-Fisher, Brian J;Scherr, Karen A;
Journal aids and behavior
Year 2020
DOI 10.1007/s10461-019-02769-1
URL
Keywords
behavior hiv decision-making cure remission plwhiv

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.